Background
==========

Diabetic nephropathy is a diabetic complication that causes end-stage renal disease \[[@b1-medscimonit-24-7007]\]. DN is characterized by microalbuminuria, renal fibrosis, extracellular matrix deposition, glomerular basement membrane thickening, and decrease in the glomerular filtration rate (GFR) \[[@b2-medscimonit-24-7007]\]. Fibrosis, inflammation, and oxidative stress play roles in the pathogenesis of DN \[[@b3-medscimonit-24-7007]\]. Production of reactive oxygen species increases, which results in oxidative stress. In end-stage renal disease, expression of NADPH oxidase 4 is altered, which plays an important role in the production of reactive oxygen species (ROS) \[[@b4-medscimonit-24-7007]\]. ROS activate many stress-related pathways and oxidative stress activates inflammation pathways. Inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interlukin-1β (IL-1β), and IL-6, are reported to occur at higher levels in patients with DN \[[@b5-medscimonit-24-7007]\]. Activation of the NF-κB pathway is associated with expression of inflammatory cytokines and transcription of NF-κB is reported to be enhanced in the development of DN \[[@b6-medscimonit-24-7007]\]. Moreover, in a STZ-induced diabetic animal model, the level of Akt was reported to be increased, which enhanced the progression of DN by increasing NF-κB \[[@b7-medscimonit-24-7007]\]. In DN, fibrosis occurs due to accumulation of extracellular matrix (ECM) because the expression of transforming growth factor beta 1 (TGF-β1) is enhanced by the activation of NF-κB \[[@b8-medscimonit-24-7007]\].

Moreover, production of nitric oxide is enhanced in the early stage of DN, and in the later stage, glomerular sclerosis occurs due to decreased production of nitric oxide (NO) \[[@b9-medscimonit-24-7007]\]. Synthesis of NO is controlled by expression of inducible nitric oxide synthase (iNOS), and in the development of DN, synthesis of iNOS is promoted by inducing TLR2-dependent signaling pathways \[[@b10-medscimonit-24-7007]\]. Thus, expression of iNOS and concentration of NO are important parameters for the development of DN.

Diosmetin is a flavonoid isolated from the leaves of the plant *Olea europaea* L \[[@b11-medscimonit-24-7007]\]. Diosmetin has effects against several types of cancer by inhibiting the activity of CYP1B1 and CYP1A1 enzyme \[[@b12-medscimonit-24-7007]\] and it attenuates the proliferation of human oral squamous carcinoma SCC-9 cells \[[@b13-medscimonit-24-7007]\]. Other pharmacological properties of diosmetin are anti-inflammatory, anti-estrogenic, anti-oxidant, anti-microbial, and anti-cancer \[[@b14-medscimonit-24-7007],[@b15-medscimonit-24-7007]\]. Moreover, on the basis of its strong anti-oxidant property, diosmetin attenuates the effects of diabetes in STZ-induced diabetic rats \[[@b16-medscimonit-24-7007]\]. Thus, the present study evaluated the nephro-protective effect of diosmetin in STZ-induced diabetic nephropathic mice.

Material and Methods
====================

Animal
------

Male albino mice (age 8--10 weeks, weight 18--25 g) were procured from Shanghai Medical College, Shanghai, China. Animals were kept in standard conditions as per guidelines. All mice were allowed to acclimatize to laboratory conditions for 7 days with free access to standard chow diet and tap water. The protocol of this study was approved by the Institutional Animal Ethics Committee of Chongqing General Hospital, China (IAEC/CGH/2017/02).

Induction of diabetic nephropathy
---------------------------------

All mice were separated into 2 groups: the control group (n=10) received citrate buffer for 5 days and the diabetic group (n=40) received STZ (50 mg/kg, i.p.) for 5 days. Subsequently, blood glucose was estimated for the confirmation of diabetes. All mice with a fasting blood glucose level above 11.1 mmol/L were considered to be diabetic and were divided into 4 subgroups: the negative control group (which received saline solution), the diosmetin 25 mg/kg group, the 50 mg/kg group, and the diosmetin 100 mg/kg, all P.O. per day for 8 weeks. At the end of the protocol, blood was collected from the tail vein and urine was collected later by keeping all the animals in metabolic cages for 1 day. The collected blood and urine were used to estimate of biochemical parameters. Thereafter, all the animals were killed by decapitation and the kidneys were removed for further study.

Determination of biochemical parameters
---------------------------------------

Kidneys were weighed and the kidney-to-body weight ratio was calculated for each animal. Blood glucose, triglyceride, BUN, and serum creatinine levels in the serum were estimated by using kits purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). The level of microalbumin was estimated using ELISA kits (R&D Systems, Minneapolis, MN, USA) as per the instructions of the manufacturer.

Determination of inflammatory mediators
---------------------------------------

Serum concentrations of the inflammatory mediators IL-6, IL-1β, and TNF-α were estimated using ELISA kits (CUSABIO, Wuhan, China) as per the instructions of the manufacturer.

Determination of oxidative stress parameters
--------------------------------------------

Isolated kidney samples were washed with normal saline solution and a tissue homogenizer was used to homogenize the kidney tissues for 5 min at 10 000 rpm in saline solution. Thereafter, tissue homogenate was centrifuged to separate the supernatant for 10 min at 10 000 rpm. In the supernatant solution, the levels of NO, MDA, and MPO and activity of SOD were determined by using kits purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China) according to the manufacturer's instructions.

Western blotting assay
----------------------

Kidney samples were homogenized with RIPA lysis buffer and protein was extracted from the sample by centrifuging at 10 000 rpm for 15 min at 4°C. BCA method was used for the estimation of total protein in the sample as per the instructions in the kit. Sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate protein from the supernatant solution equivalent to 50 μg of protein. Protein was poured on the membrane and then tris buffer was used to block binding to the membrane for 60 min. Rabbit polyclonal anti-NF-κB p65 (1: 1000), anti-inducible NO synthase (iNOS) \[1: 1000\], anti-Akt (1: 1000), and anti-pAkt (1: 1000) antibody (Proteintech Group, Inc, Wuhan, China) were incubated with the blots at 4°C for overnight. Later, secondary rabbit anti-mouse IgG horseradish peroxidase (HRP) antibody (Proteintech Group Inc, Wuhan, China) was used to incubate for 60 min at room temperature after washing the membrane with TBST. An ECL detection system was used for development and detection of blots.

Immunohistochemistry
--------------------

Isolated kidney samples were fixed in a 10% formalin solution, dehydrated, and embedded in liquid paraffin. Then, 5-μm-thick tissue sections of were cut from the wax cubes using a microtome. Tissues were rehydrated in ethanol and boiled for 15 min with EDTA in a microwave oven for the retrieval of antigen. Hydrogen peroxide solution was used to block the activity of endogenous peroxidase enzyme. Anti-NF-κB p65 was incubated at 4°C overnight with tissue slides after washing it with PBS. The Envision Detection Kit was used to detect the antibody, and hematoxylin was used to counterstain the tissue sections. A trinocular microscope was used to examine the tissue sections.

Statistical analysis
--------------------

All data are expressed as mean ±SEM (n=10). The statistical analysis was performed using one-way ANOVA. Post hoc comparison of means was carried out by Dunnett's post hoc test (Gradpad prism 6.1., CA, USA) for multiple comparisons. The level of statistical significance was set at P\<0.05.

Results
=======

Effect of diosmetin on fasting blood glucose and kidney/body weight
-------------------------------------------------------------------

The effect of diosmetin on serum concentration of fasting blood glucose and kidney/body weight in STZ-induced DN mice was shown in [Figure 1](#f1-medscimonit-24-7007){ref-type="fig"}. We found that the fasting blood glucose levels were significantly higher in all groups treated with STZ on day 0 of the protocol compared to the control group. However, FBG was significantly higher at week 8 of the protocol in the negative control group compared to the control group. Treatment with diosmetin significantly reduced FBG in a dose-dependent manner compared to the negative control group. The kidney/body weight ratio was also significatly higher (p\<0.01) in the negative control group compared to the control group. There was a significant decrease in kidney/body weight ratio in the diosmetin-treated group compared to the negative control group.

Effect of diosmetin on the biochemical parameters
-------------------------------------------------

The effects of diosmetin on the concentrations of triglyceride, creatinine, and BUN in serum and albumin concentration in urine of STZ-induced DN mice are shown in [Figure 2](#f2-medscimonit-24-7007){ref-type="fig"}. There was a significant increase in the concentration of triglyceride, creatinine, and BUN in serum and albumin concentration in urine of the negative control group compared to the control group. However, treatment with diosmetin attenuated the altered level of triglyceride, creatinine, and BUN in serum and albumin concentration in urine of STZ-induced diabetic mice. Alteration of these biochemical parameter confirms that DN was induced in the negative control group and that treatment with diosmetin attenuated the DN in STZ-induced diabetic mice.

Effect of diosmetin on inflammatory mediators
---------------------------------------------

Effect of diosmetin on the concentration of inflammatory mediators in the serum of STZ-induced DN mice is shown in [Figure 3](#f3-medscimonit-24-7007){ref-type="fig"}. The levels inflammatory mediators TNF-α, IL-6, and IL-1β were significantly enhanced in the serum of the negative control group compared to the control group. There was a significant decrease in the levels of TNF-α, IL-6, and IL-1β in the serum of the diosmetin-treated group compared to the negative control group.

Effect of diosmetin on the parameters of oxidative stress
---------------------------------------------------------

The effect of diosmetin on the oxidative stress parameters was estimated by determining the activity of SOD and MPO enzymes and the levels of NO and MDA in the kidney tissue homogenate of STZ-induced DN mice ([Figure 4](#f4-medscimonit-24-7007){ref-type="fig"}.). There was a significant increase in the level of MDA and a decrease in NO level in the tissue homogenate of the negative control group compared to the control group. Moreover, the activity of SOD was significantly reduced and the MPO enzyme activity was increased in the tissue homogenate of the diosmetin-treated group compared to the negative control group. However, treatment with diosmetin attenuated the altered levels of MDA and NO and the activity of SOD and MPO in the tissue homogenate of STZ-induced DN mice.

Effect of diosmetin on the expressions of p-Akt, NF-κB, and iNOS
----------------------------------------------------------------

[Figure 5](#f5-medscimonit-24-7007){ref-type="fig"} shows the effects of diosmetin on the expressions of p-Akt, NF-κB, and iNOS in the kidney tissue homogenate of STZ-induced DN mice. The expression of p-Akt and NF-κB was significantly enhanced and expression of iNOS was decreased in the tissue homogenate of the negative control group compared to the control group. However, treatment with diosmetin significantly attenuated the altered expressions of p-Akt, NF-κB, and iNOS in the kidney tissue homogenate of STZ-induced DN mice in a dose-dependent manner.

Effect of diosmetin on immunohistochemical analysis of NF-κB
------------------------------------------------------------

The effect of diosmetin on the immunohistochemical analysis of NF-κB in the tissue homogenate of kidney of STZ-induced DN mice is shown in [Figure 6](#f6-medscimonit-24-7007){ref-type="fig"}. There was significant enhancement in the expression of NF-κB p65 in the cytoplasm and nucleus of tubular and glomerular cell of the negative control group compared to the control group. However, treatment with diosmetin attenuated the expression of NF-κB p65 in the renal tissues of STZ-induced DN mice.

Discussion
==========

In diabetes, chronic hyperglycemia leads to various complications, such as diabetic neuropathy, gastroparesis, retinopathy, and diabetic nephropathy \[[@b17-medscimonit-24-7007]\]. DN is the major complication of diabetes and blood pressure is reported to be increased in these patients. The literature reveals that drugs used for the management of DN reduce the blood pressure \[[@b18-medscimonit-24-7007]\]. Diosmetin is reported to possess anti-diabetic, anti-inflammatory, anti-oxidant, and anti-cancer properties \[[@b14-medscimonit-24-7007]--[@b16-medscimonit-24-7007]\]. Thus, the present study evaluated the nephroprotective effect of diosmetin in STZ-induced DN mice. Diabetes was induced by injecting STZ (50 mg/kg) i.p. for 5 days. Biochemical parameters, including fasting blood glucose, creatinine, BUN in the serum, and albumin in the urine, were determined in STZ-induced DN mice. Moreover, the level of inflammatory mediators in the serum and oxidative stress parameters in the tissue homogenate was assessed in STZ-induced DN mice. Expressions of Akt, NF-κB, and iNOS in the tissue homogenate were estimated by Western blot analysis.

Several biochemical parameters, including creatinine and urea level in the serum and microalbumin urea in urine, are markers of DN \[[@b19-medscimonit-24-7007]\]. Our data also showed that the levels of these biochemical parameters were altered in the negative control group and that treatment with diosmetin attenuated the altered levels of in the serum and urine of STZ-induced DN mice. The literature reveals that in diabetes, the level of oxidative stress is enhanced, which affects the pathogenesis of DN \[[@b20-medscimonit-24-7007]\]. Results of the present study reveal that treatment with diosmetin significantly attenuated the altered level of level of oxidative stress in the tissue homogenate of STZ-induced DN mice in a dose-dependent manner. Several cellular processes, including angiogenesis, metabolism, growth, survival, and proliferation, were reported to be regulated by Akt and PI3K/Akt pathways involved in DN \[[@b21-medscimonit-24-7007]\]. A previous study reported that several molecules for the management renal dysfunction attenuate the Akt pathway \[[@b22-medscimonit-24-7007]\]. Results of the present study reveal that diosmetin attenuated the altered expression of Akt protein in the renal tissue of DN mice.

The inflammatory cytokines IL-6, IL-1β, and TNF-α were reported to be involved in the development of DN by stimulating the NF-κB signaling pathway \[[@b23-medscimonit-24-7007],[@b24-medscimonit-24-7007]\]. In DN, inflammation occurs by activating the NF-κB signaling pathway and by enhanced oxidative stress \[[@b25-medscimonit-24-7007],[@b26-medscimonit-24-7007]\]. Data of the present study reveal that diosmetin attenuates the altered level of inflammatory cytokines in the serum of DN mice. Moreover, diosmetin reduced the expression of NF-κB protein the tissue homogenate of DN mice compared to the negative control group.

Development of renal injury occurs due to decrease in the level of NO and is involved in cardiovascular diseases. Several studies report that the production of NO is enhanced by iNOS and is thereby involved in renal injury \[[@b27-medscimonit-24-7007]\]. We found that the expression of iNOS was significantly lower in the diosmetin-treated group compared to the negative control group of mice.

Conclusions
===========

Our study shows that diosmetin protects against renal injury in STZ-induced diabetic nephropathy mice by modulating the Akt/NF-κB/iNOS signaling pathway. Our results reveal that oxidative stress parameters and inflammatory mediator levels were significantly reduced by diosmetin in STZ-induced DN mice.
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